ESR1 and breast cancer: However, overexpression of CaV3.2 failed to increase the expression of ESR1 in HER2-positive SKBR3 cell line (luminal type) suggesting that overexpression of CaV3.2 perhaps is not the driving force for the pathogenesis of luminal type breast cancer.